Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Heart Diseases 3 Vascular Diseases 2 Small Cell Lung Carcinoma 2 Cardiovascular Diseases 2 Cardiotoxicity 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Cancer Resectable 1 Ovarian Carcinosarcoma 1 Neoplasms, Second Primary 1 Myelodysplastic Syndromes 1 Metabolic Diseases 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Immune-related Adverse Event 1 Hematologic Neoplasms 1 Heart Failure 1 Esophageal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoma, Hepatocellular 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasms 1 Advanced Ovarian Cancer 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Carcinosarcoma × Antineoplastic Agents × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡